OTCMKTS:EKTAY

Elekta AB (publ) Stock Forecast, Price & News

$14.02

-0.44 (-3.04 %)

(As of 01/25/2021 05:19 PM ET)

Add

Compare

Today's Range

$13.91

Now: $14.02▼

$14.02

50-Day Range

$12.74

MA: $13.34▼

$14.27

52-Week Range

$6.25

Now: $14.02▼

$14.51

Volume2,628 shs

Average Volume4,470 shs

Market Capitalization$5.36 billion

P/E Ratio39.37

Dividend Yield0.97%

Beta0.85

Elekta AB (publ), a medical technology company, provides clinical solutions for cancer and brain disorders worldwide. The company offers radiotherapy treatment systems, such as Versa HD, a dose delivery accuracy system; Elekta Infinity, an image-guided radiation therapy (IGRT) system; and Elekta Synergy, a digital accelerator for advanced IGRT. It also provides personalized imaging tools; automation and integration systems; beam shaping solutions; patient positioning and immobilization solutions; and radiotherapy treatment planning systems. In addition, the company offers radiosurgery systems under the Leksell Gamma Knife Icon, Leksell Gamma Knife Perfexion, and Elekta Axesse names; Leksell GammaPlan, a treatment planning software; and Elekta Unity, a magnetic resonance radiation therapy solution. Further, it provides care management software, such as MOSAIQ Radiation Oncology and MOSAIQ Medical Oncology; MOSAIQ IQ Scripts, a workflow automation and customization tool; Patient Engagement, a patient communication tool; MOSAIQ Evaluate, a plan management and dose review solution; MOSAIQ Locate, a stereotactic localization solution; and METRIQ, a cancer registry data management solution. Additionally, the company offers Flexitron, a remote after loading platform; Esteya, an electronic brachytherapy for treating skin cancer; Oncentra Brachy, a treatment planning software; real-time prostate solutions; and gynecological brachytherapy, bronchus and esophagus, breast, prostate, rectum and bladder, and skin applicators, as well as brachytherapy needles and flexible implant tubes. It also provides Leksell Vantage Stereotactic System for neuroimaging and treatment; Leksell Stereotactic System for minimally invasive stereotactic neurosurgery; and proton therapy components. The company was founded in 1972 and is headquartered in Stockholm, Sweden.

MarketRank^™

Overall MarketRank^™

0.84 out of 5 stars

Medical Sector

1091st out of 1,922 stocks

Medical Laboratories Industry

24th out of 39 stocks

0.0 Analyst's Opinion

Consensus Rating
There is not enough analysis data for Elekta AB (publ).

2.1 Community Rank

Outperform Votes
Elekta AB (publ) has received 209 “outperform” votes. (Add your “outperform” vote.)
Underperform Votes
Elekta AB (publ) has received 281 “underperform” votes. (Add your “underperform” vote.)
Community Sentiment
Elekta AB (publ) has received 57.35% “underperform” votes from our community.

MarketBeat's community ratings are surveys of what our community members think about Elekta AB (publ) and other stocks. Vote “Outperform” if you believe EKTAY will outperform the S&P 500 over the long term. Vote “Underperform” if you believe EKTAY will underperform the S&P 500 over the long term. You may vote once every thirty days.

0.8 Dividend Strength

Dividend Yield
Elekta AB (publ) has a dividend yield of 0.97%, which is in the bottom 25% of all stocks that pay dividends.
Dividend Growth
Elekta AB (publ) does not have a long track record of dividend growth.
Dividend Sustainability
Based on earnings estimates, Elekta AB (publ) will have a dividend payout ratio of 29.79% next year. This indicates that Elekta AB (publ) will be able to sustain or increase its dividend.

0.0 Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Elekta AB (publ) insiders have not sold or bought any company stock.
Percentage Held by Institutions
Only 0.02% of the stock of Elekta AB (publ) is held by institutions.

1.3 Earnings and Valuation

Earnings Growth
Earnings for Elekta AB (publ) are expected to grow by 11.90% in the coming year, from $0.42 to $0.47 per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of Elekta AB (publ) is 39.37, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 24.31.
Price to Earnings Ratio vs. Sector
The P/E ratio of Elekta AB (publ) is 39.37, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 36.58.
Price to Book Value per Share Ratio
Elekta AB (publ) has a P/B Ratio of 6.20. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

Industry, Sector and Symbol

Stock Exchange OTCMKTS

Industry Medical laboratories

Sub-IndustryN/A

SectorMedical

Current SymbolOTCMKTS:EKTAY

Previous Symbol

CUSIPN/A

CIKN/A

Webwww.elekta.com

Phone46-8-587-254-00

Employees3,800

Year FoundedN/A

Debt

Debt-to-Equity RatioN/A

Current RatioN/A

Quick RatioN/A

Price-To-Earnings

Trailing P/E Ratio39.37

Forward P/E Ratio33.38

P/E GrowthN/A

Sales & Book Value

Annual Sales$1.44 billion

Price / Sales3.73

Cash Flow$0.63 per share

Price / Cash Flow22.10

Book Value$2.26 per share

Price / Book6.20

Profitability

EPS (Most Recent Fiscal Year)N/A

Net IncomeN/A

Net MarginsN/A

Return on EquityN/A

Return on AssetsN/A

Miscellaneous

Outstanding Shares382,030,000

Market Cap$5.36 billion

Next Earnings Date1/28/2021 (Estimated)

OptionableNot Optionable

$14.02

-0.44 (-3.04 %)

(As of 01/25/2021 05:19 PM ET)

30 days | 90 days | 365 days | Advanced Chart

Receive EKTAY News and Ratings via Email

Sign-up to receive the latest news and ratings for EKTAY and its competitors with MarketBeat's FREE daily newsletter.

Elekta AB (publ) (OTCMKTS:EKTAY) Frequently Asked Questions

How has Elekta AB (publ)'s stock price been impacted by Coronavirus (COVID-19)?

Elekta AB (publ)'s stock was trading at $9.29 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, EKTAY shares have increased by 55.7% and is now trading at $14.46.
View which stocks have been most impacted by COVID-19.

Is Elekta AB (publ) a buy right now?

6 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Elekta AB (publ) in the last twelve months. There are currently 1 sell rating, 3 hold ratings and 2 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" Elekta AB (publ) stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in EKTAY, but not buy additional shares or sell existing shares.
View analyst ratings for Elekta AB (publ) or view MarketBeat's top 5 stock picks.

What stocks does MarketBeat like better than Elekta AB (publ)?

Wall Street analysts have given Elekta AB (publ) a "Hold" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Elekta AB (publ) wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

When is Elekta AB (publ)'s next earnings date?

Elekta AB (publ) is scheduled to release its next quarterly earnings announcement on Thursday, January 28th 2021.
View our earnings forecast for Elekta AB (publ).

How often does Elekta AB (publ) pay dividends? What is the dividend yield for Elekta AB (publ)?

Elekta AB (publ) announced a Semi-Annual dividend on Tuesday, July 21st. Shareholders of record on Friday, August 28th will be paid a dividend of $0.069 per share on Thursday, September 17th. The ex-dividend date is Thursday, August 27th. This is an increase from Elekta AB (publ)'s previous Semi-Annual dividend of $0.05.
View Elekta AB (publ)'s dividend history.

Is Elekta AB (publ) a good dividend stock?

Elekta AB (publ) pays an annual dividend of $0.14 per share and currently has a dividend yield of 0.97%.
View Elekta AB (publ)'s dividend history.

Are investors shorting Elekta AB (publ)?

Elekta AB (publ) saw a increase in short interest during the month of December. As of December 31st, there was short interest totaling 2,400 shares, an increase of 200.0% from the December 15th total of 800 shares. Based on an average trading volume of 4,700 shares, the short-interest ratio is currently 0.5 days.
View Elekta AB (publ)'s Short Interest.

Who are some of Elekta AB (publ)'s key competitors?

Some companies that are related to Elekta AB (publ) include Quest Diagnostics (DGX), Guardant Health (GH), Natera (NTRA), Invitae (NVTA), CareDx (CDNA), Burning Rock Biotech (BNR), Veracyte (VCYT), Genetron (GTH), Personalis (PSNL), Fulgent Genetics (FLGT), Castle Biosciences (CSTL), RadNet (RDNT), Renalytix AI (RNLX), DermTech (DMTK) and Progenity (PROG).
View all of EKTAY's competitors.

Who are Elekta AB (publ)'s key executives?

Elekta AB (publ)'s management team includes the following people:

Dr. Laurent Leksell, Founder & Chairman (Age 68)
Mr. Gustaf Salford, Pres & CEO (Age 43)
Mr. Johan Adeback, Group Treasurer & Acting CFO (Age 56)
Cecilia Ketels, Head of Investor Relations
Mr. Jonas Bolander, Gen. Counsel, Sec. & Exec. VP (Age 54)
Mr. Mattias Thorsson, Head of Corp. Communications & Public Affairs
Mr. Ioannis Panagiotelis, Exec. VP of APAC, Japan & South America and Chief Marketing & Sales Officer (Age 48)
Ms. Karin Svenske Nyberg, Exec. VP of HR (Age 54)
Mr. James P. Hoey, Head of External Relations (Age 62)

What is Elekta AB (publ)'s stock symbol?

Elekta AB (publ) trades on the OTCMKTS under the ticker symbol "EKTAY."

How do I buy shares of Elekta AB (publ)?

Shares of EKTAY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Elekta AB (publ)'s stock price today?

One share of EKTAY stock can currently be purchased for approximately $14.46.

How big of a company is Elekta AB (publ)?

Elekta AB (publ) has a market capitalization of $5.52 billion and generates $1.44 billion in revenue each year. Elekta AB (publ) employs 3,800 workers across the globe.

What is Elekta AB (publ)'s official website?

The official website for Elekta AB (publ) is www.elekta.com.

How can I contact Elekta AB (publ)?

Elekta AB (publ)'s mailing address is P.O. Box 7593, Stockholm V7, SE-103 93. The company can be reached via phone at 46-8-587-254-00 or via email at [email protected]

This page was last updated on 1/25/2021 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here